XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.2

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2025

Summary of Significant Accounting Policies [Abstract]

Summary of reconciliation of cash and cash equivalents

​

​	​	​	​	​	​	​
​		June 30, 2025			December 31, 2024
Cash and cash equivalents	​	$	38,258	​	$	27,572
Cash and cash equivalents of held for sale - discontinued operations	​		38,829	​		21,810
Total cash and cash equivalents	​	$	77,087	​	$	49,382

Summary of net revenue by product category

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

June 30,

​

June 30,

​

​

2025

​

2024

​

2025

​

2024

Diabetes

​

$

191,056

​

$

194,361

​

$

378,416

​

$

374,351

Sleep therapy

​

​

181,622

​

​

170,237

​

​

363,481

​

​

342,274

Home respiratory therapy

​

​

109,526

​

​

109,687

​

​

218,132

​

​

218,495

Ostomy

​

​

51,893

​

​

47,059

​

​

101,392

​

​

91,626

Wound care

​

​

46,822

​

​

47,156

​

​

93,468

​

​

90,393

Urology

​

​

28,696

​

​

25,645

​

​

56,839

​

​

50,634

Other

​

72,302

​

​

66,256

​

144,073

​

​

130,471

Net revenue

​

$

681,917

​

$

660,401

​

$

1,355,801

​

$

1,298,244

​

The following table summarizes net revenue by payor type:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

June 30,

​

June 30,

​

​

2025

​

2024

​

2025

​

2024

Commercial payors (1)

​

$

550,828

​

$

535,626

​

$

1,094,356

​

$

1,053,039

Medicare

​

​

121,724

​

​

114,573

​

​

242,054

​

​

225,042

Medicaid

​

​

9,365

​

​

10,202

​

​

19,391

​

​

20,163

Net revenue

​

$

681,917

​

$

660,401

​

$

1,355,801

​

$

1,298,244

⁽¹⁾ Includes revenue from Medicare Advantage Payors of approximately $178 million and $172 million for the three months ended June 30, 2025 and 2024 and approximately $349 million and $337 million for the six months ended June 30, 2025 and 2024.

Schedule of cost of revenue

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

Six Months Ended

​

​

June 30,

​

June 30,

​

​

2025

2024

​

2025

2024

Cost of product sold

​

$

319,517

​

$

305,496

​

$

636,906

​

$

603,864

Patient service equipment depreciation

​

​

31,883

​

​

31,621

​

​

63,566

​

​

64,039

Other costs

​

​

5,915

​

​

7,255

​

​

11,485

​

​

14,720

Cost of net revenue

​

$

357,315

​

$

344,372

​

$

711,957

​

$

682,623

X

- Definition

Tabular disclosure of information about cost of revenue.

+ References

No definition available.

+ Details

Name:	omi_CostOfRevenueTableTextBlock
Namespace Prefix:	omi_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(1)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482913/230-10-50-8

+ Details

Name:	us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration